Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000226574 | SCV000286704 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618429 | SCV000736545 | likely benign | Cardiovascular phenotype | 2020-07-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000764332 | SCV000895351 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001551023 | SCV001771441 | likely benign | not provided | 2020-07-08 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31983221) |
Revvity Omics, |
RCV001551023 | SCV003825511 | uncertain significance | not provided | 2019-07-08 | criteria provided, single submitter | clinical testing |